NCT04253431 - The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DEVICE

Droplet lancing device (HTL-Strefa S.A.)

DEVICE

Microlet 2 lancing device (Bayer)

DEVICE

OneTouch Delicia lancing device (LifeScan)

DEVICE

ReliOn lancing device (ReliOn)

DEVICE

Accu-Chek Softclix lancing device (Roche)

DEVICE

BGStar lancing device (Sanofi Aventis)

DEVICE

Ultra-Fine 33G lancets (BD)

DEVICE

Droplet 33G lancets (HTL-Strefa S.A.)

DEVICE

OneTouch Delicia Extra Fine 33G lancets (LifeScan)

DEVICE

HaemoFine 33G lancets (HTL-Strefa S.A.)

DEVICE

Softclix 28 G lancets (Roche)

DEVICE

ReliOn Ultra-Thin Plus 33G lancets (ReliOn)

DEVICE

GlucoJect Dual S lancing device (Menarini)

DEVICE

Microlet 28G lancets (Bayer)

DEVICE

BGStar Ultra-Thin 33G lancets (Sanofi Aventis)

All Listed Sponsors

lead

HTL-Strefa S.A.

INDUSTRY